Eli Lilly and (LLY)
undefined
undefined%
At close: undefined
762.54
-0.20%
Pre-market Jan 07, 2025, 05:38 AM EST

Eli Lilly and Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013Dec 31, 2012Sep 30, 2012Jun 30, 2012Mar 31, 2012Jun 30, 2011Mar 31, 2011
Immunology Revenue 1.19B 834.00M 986.90M 928.50M 777.80M 866.40M 796.50M 748.10M 1.00B 785.40M 613.90M 627.10M 548.30M 585.80M 454.60M 456.10M 334.70M 894.50M 966.90M 861.30M 922.60M 759.00M 887.90M 869.90M 893.70M 964.40M 1.48B 1.88B 2.00B 1.85B 2.03B 1.82B 1.82B 1.90B 2.65B 53.60M
Immunology Revenue Growth +42.17% -15.49% +6.29% +19.38% -10.23% +8.78% +6.47% -25.55% +27.95% +27.94% -2.10% +14.37% -6.40% +28.86% -0.33% +36.27% -62.58% -7.49% +12.26% -6.64% +21.55% -14.52% +2.07% -2.66% -7.33% -35.05% -20.94% -6.31% +8.42% -8.98% +11.86% -0.48% -4.16% -28.27% +4851.12% n/a
Neuroscience Revenue 351.80M 389.10M 1.77B 387.20M 360.50M 373.20M 389.90M 397.70M 450.20M 512.20M 465.40M 470.70M 422.50M 463.50M 426.70M 452.70M 393.10M 643.70M 721.70M 724.50M 763.90M 725.30M 868.50M 882.40M 858.40M 764.30M 874.40M 821.80M 808.10M 764.20M 839.20M 791.70M 846.80M 803.90M 825.80M 2.41B
Neuroscience Revenue Growth -9.59% -77.99% +356.64% +7.41% -3.40% -4.28% -1.96% -11.66% -12.10% +10.06% -1.13% +11.41% -8.85% +8.62% -5.74% +15.16% -38.93% -10.81% -0.39% -5.16% +5.32% -16.49% -1.58% +2.80% +12.31% -12.59% +6.40% +1.70% +5.74% -8.94% +6.00% -6.51% +5.34% -2.65% -65.66% n/a
Oncology Revenue 2.23B 1.81B 1.75B 1.67B 1.36B 1.29B 1.37B 1.35B 1.41B 1.55B 1.37B 1.33B 1.27B 1.20B 1.15B 1.20B 1.01B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 59.50M 839.90M
Oncology Revenue Growth +23.30% +3.60% +4.55% +23.23% +4.85% -5.51% +1.16% -3.78% -9.52% +13.25% +2.91% +5.11% +5.58% +4.72% -4.16% +18.22% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -92.92% n/a
Other Product Revenue 53.20M 41.30M 42.90M 51.00M 52.80M 66.60M 80.10M 98.10M 88.80M 64.60M 107.50M 97.00M 97.60M 174.70M 119.20M 123.30M 113.40M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Product Revenue Growth +28.81% -3.73% -15.88% -3.41% -20.72% -16.85% -18.35% +10.47% +37.46% -39.91% +10.82% -0.61% -44.13% +46.56% -3.33% +8.73% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012
China Revenue 1.54B 1.45B 1.66B 1.12B 3.77B 4.23B 3.94B 3.77B 3.94B 4.51B 4.34B 4.26B
China Revenue Growth +5.98% -12.56% +48.75% -70.33% -11.02% +7.30% +4.65% -4.45% -12.49% +3.88% +1.85% n/a
Europe Revenue 6.17B 4.30B 4.78B 4.19B 2.55B 2.49B 2.42B 2.33B 2.03B 2.03B 3.82B 3.78B
Europe Revenue Growth +43.62% -10.00% +14.07% +64.38% +2.16% +3.06% +3.81% +14.65% +0.30% -46.95% +0.97% n/a
Japan Revenue 1.67B 1.75B 2.37B 2.58B 3.28B 3.96B 3.72B 3.62B 3.88B 3.95B n/a n/a
Japan Revenue Growth -4.28% -26.18% -8.37% -21.35% -16.97% +6.24% +2.94% -6.89% -1.60% n/a n/a n/a
Other Foreign Countries Revenue 2.95B 2.85B 2.70B 2.42B 12.72B n/a 12.79B 11.51B 10.10B 9.13B n/a n/a
Other Foreign Countries Revenue Growth +3.30% +5.54% +11.54% -80.96% n/a n/a +11.11% +13.95% +10.55% n/a n/a n/a
United States Revenue 21.79B 18.19B 16.81B 14.23B n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth +19.80% +8.20% +18.14% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 2.10B 2.12B 1.95B 1.92B 1.80B 1.93B 1.75B 1.64B 1.61B 1.63B 1.56B 1.59B 1.58B 1.69B 1.58B 1.55B 1.57B 1.45B 1.55B 1.70B 1.41B 1.59B 1.52B 1.86B 1.62B 1.65B 1.50B 1.78B 1.56B 1.71B 1.54B 1.79B 1.57B 1.62B 1.47B 1.80B 1.58B 1.64B 1.52B
Selling, General, and Administrative Revenue Growth -0.83% +8.46% +1.43% +6.69% -6.31% +10.07% +6.45% +1.80% -0.67% +4.31% -2.14% +0.89% -6.39% +6.96% +1.42% -0.97% +8.32% -6.52% -8.75% +20.24% -10.97% +4.56% -18.50% +15.15% -2.24% +10.25% -15.75% +14.46% -8.90% +10.53% -13.71% +14.35% -3.53% +10.09% -18.04% +14.13% -3.65% +7.34% n/a
Research and Development Revenue 2.73B 2.71B 2.52B 2.56B 2.41B 2.36B 1.99B 2.00B 1.80B 1.78B 1.61B 1.96B 1.71B 1.67B 1.68B 1.84B 1.47B 1.39B 1.39B 1.58B 1.38B 1.40B 1.23B 1.45B 1.34B 1.33B 1.18B 1.47B 1.32B 1.25B 1.24B 1.45B 1.24B 1.34B 1.22B 1.44B 1.14B 1.17B 1.04B
Research and Development Revenue Growth +0.84% +7.47% -1.56% +6.38% +2.23% +18.71% -0.54% +10.70% +1.18% +10.67% -17.83% +14.66% +2.16% -0.71% -8.34% +25.43% +5.41% -0.14% -11.97% +14.52% -1.52% +13.95% -15.36% +8.23% +0.77% +13.27% -20.11% +11.66% +5.48% +1.02% -14.64% +17.32% -7.45% +9.41% -15.45% +26.31% -2.23% +12.53% n/a